In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis

• Published in: Experimental parasitology Vol. 251; p. 108555
• Main Authors: Freitas, Camila S., Santiago, Samira S., Lage, Daniela P., Antinarelli, Luciana M.R., Oliveira, Fabrício M., Vale, Danniele L., Martins, Vívian T., Magalhaes, Lícia N.D., Bandeira, Raquel S., Ramos, Fernanda F., Pereira, Isabela A.G., de Jesus, Marcelo M., Ludolf, Fernanda, Tavares, Grasiele S.V., Costa, Adilson V., Ferreira, Rafaela S., Coimbra, Elaine S., Teixeira, Róbson R., Coelho, Eduardo A.F.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.08.2023
• Subjects: Amphotericin B; Amphotericin B - therapeutic use; Amphotericin B - toxicity; Animals; Antiprotozoal Agents - therapeutic use; Antiprotozoal Agents - toxicity; Immune response; Leishmania infantum; Leishmaniasis; Leishmaniasis - drug therapy; Leishmaniasis, Visceral - drug therapy; Leishmaniasis, Visceral - parasitology; Mice; Mice, Inbred BALB C; Toxicity; Treatment; Vanillin; Treatment; Immune response; Leishmaniasis; Vanillin; Amphotericin B; Toxicity
• ISSN: 0014-4894; 1090-2449
• DOI: 10.1016/j.exppara.2023.108555

The treatment against leishmaniasis presents problems, mainly due to their toxicity of the drugs, high cost and/or by the emergence of parasite resistant strains. In this context, new therapeutics should be searched. In this study, two novel synthetic derivatives from vanillin: [4-(2-hydroxy-3-(4-octyl-1H-1,2,3-triazol-1-yl)propoxy)-3-methoxybenzaldehyde] or 3s and [4-(3-(4-decyl-1H-1,2,3-triazol-1-yl)-2-hydroxypropoxy)-3-methoxybenzaldehyde] or 3t, were evaluated regarding their antileishmanial activity against distinct parasite species able to cause cutaneous and visceral leishmaniasis. Results showed that compounds 3s and 3t were effective against Leishmania infantum, L. amazonensis and L. braziliensis promastigote and amastigote-like forms, showing selectivity index (SI) of 25.1, 18.2 and 22.9, respectively, when 3s was used against promastigotes, and of 45.2, 7.5 and 15.0, respectively, against amastigote-like stage. Using the compound 3t, SI values were 45.2, 53.0 and 80.0, respectively, against promastigotes, and of 35.9, 46.0 and 58.4, respectively, against amastigote-like forms. Amphotericin B (AmpB) showed SI values of 5.0, 7.5 and 15.0, respectively, against promastigotes, and of 3.8, 5.0 and 7.5, respectively, against amastigote-like stage. The treatment of infected macrophages and inhibition of the infection upon pre-incubation with the molecules showed that they were effective in reducing the infection degree and inhibiting the infection in pre-incubated parasites, respectively, as compared to data obtained using AmpB. The mechanism of action of 3s and 3t was evaluated in L. infantum, revealing that both 3s and 3t altered the parasite mitochondrial membrane potential leading to reactive oxygen species production, increase in lipid corps and changes in the cell cycle, causing the parasite’ death. A preliminary assay using the cell culture supernatant from treated and infected macrophages showed that 3s and 3t induced higher IL-12 and lower IL-10 values; suggesting the development of an in vitro Th1-type response in the treated cells. In this context, data indicated that 3s and 3t could be considered therapeutic agents to be tested in future studies against leishmaniasis. [Display omitted] •Two vanillin synthetic derivatives were tested against Leishmania.•They were effective against promastigotes and intracellular amastigotes.•Low toxicity in two mammalian cells was found.•The molecules altered the parasite mitochondria causing cell death.•Th1-type cytokines were produced after treatment of infected macrophages.